{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:54:37Z","timestamp":1781848477019,"version":"3.54.5"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Homocystinuria is a hereditary metabolic disorder primarily caused by defects in enzymes involved in methionine metabolism, resulting in excessive accumulation of homocysteine and its metabolites in the blood and urine. Cerebral venous sinus thrombosis (CVST), premature atherosclerosis, and other thromboembolic events are among the most serious clinical manifestations of homocystinuria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report a 13-year-old boy who initially presented with headache, followed by progressive disturbance of consciousness and status epilepticus. Cranial magnetic resonance imaging (MRI) revealed superior sagittal sinus thrombosis. He was transferred to a tertiary hospital, where he underwent emergency thrombus aspiration under digital subtraction angiography (DSA) guidance and received low-molecular-weight heparin (LMWH) anticoagulation. Although endovascular aspiration combined with LMWH controlled the seizures, his venous thrombosis continued to progress. He subsequently developed lower-extremity deep vein thrombosis, acute pulmonary embolism, and ventricular fibrillation. Clinical biochemical evaluation and genetic testing confirmed classic homocystinuria. Targeted therapy with warfarin, aspirin, vitamin B6, folic acid, and betaine resulted in a favorable prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early etiological screening, including genetic testing, should be prioritized in young patients with unexplained or recurrent thrombosis to optimize treatment and prognosis. Rational use of anticoagulants combined with targeted metabolic therapy (vitamin B6, folic acid, betaine) and antiplatelet therapy is critical for improving outcomes in such patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1825770","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:46:58Z","timestamp":1781848018000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Homocystinuria presenting with cerebral venous thrombosis: a case report highlighting progressive thrombosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaomin","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Surgical Intensive Care Unit, Children's Hospital of Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgical Intensive Care Unit, Children's Hospital of Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Children's Hospital of Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Children's Hospital of Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00018-022-04456-9","article-title":"H\u2082S biogenesis by cystathionine beta-synthase: mechanism of inhibition by aminooxyacetic acid and unexpected role of serine","volume":"79","author":"Petrosino","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ajmg.1320350413","article-title":"Pyridoxine-unresponsive homocystinuria with an unusual clinical course","volume":"35","author":"Cochran","year":"2022","journal-title":"Am J Med Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jtha.2022.11.014","article-title":"Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the scientific and standardization committees on perioperative and critical care haemostasis and thrombosis of the international society on thrombosis and haemostasis","volume":"21","author":"Helms","year":"2023","journal-title":"J Thromb Haemost"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1161\/STR.0000000000000456","article-title":"Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association","volume":"55","author":"Saposnik","year":"2024","journal-title":"Stroke"},{"key":"B5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12913-020-04962-9","article-title":"Prevalence, characteristics, and costs of diagnosed homocystinuria, elevated homocysteine, and phenylketonuria in the United States: a retrospective claims-based comparison","volume":"20","author":"Sellos-Moura","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10545-016-9994-5","article-title":"Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency","volume":"40","author":"Morris","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/svn-2019-000323","article-title":"Chinese stroke association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis","volume":"5","author":"Fan","year":"2020","journal-title":"Stroke Vasc Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00000658-194101000-00014","article-title":"The treatment of staphylococcal cavernous sinus thrombophlebitis with heparin and chemotherapy","volume":"113","author":"Lyons","year":"1941","journal-title":"Ann Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/2396987317712882","article-title":"European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis: endorsed by the European academy of neurology","volume":"2","author":"Ferro","year":"2017","journal-title":"Eur Stroke J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s42466-024-00432-9","article-title":"New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline","volume":"6","author":"Weimar","year":"2024","journal-title":"Neurol Res Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1172\/JCI116709","article-title":"Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells","volume":"92","author":"Valles","year":"1993","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1172\/JCI112435","article-title":"Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine","volume":"77","author":"Starkebaum","year":"1986","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra050115","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"64S","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, clinical use, and monitoring","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"B1","DOI":"10.1016\/S0049-3848(97)00138-5","article-title":"Mechanisms of action of heparin and low molecular weight heparin","volume":"87","author":"Weitz","year":"1997","journal-title":"Thromb Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature02214","article-title":"Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2","volume":"427","author":"Rost","year":"2004","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/MPH.0000000000000623","article-title":"Heparin-resistant thrombosis due to homozygous antithrombin deficiency treated with rivaroxaban: a case report","volume":"38","author":"Schluckebier","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12959-025-00748-9","article-title":"Anticoagulant management in an antithrombin-deficient pregnant woman with a history of venous thromboembolism: a case report","volume":"23","author":"Kozak","year":"2025","journal-title":"Thromb J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1229","article-title":"Clinvar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Wicker","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1098-1004(1999)13:5<362::AID-HUMU4>3.0.CO;2-K","article-title":"Cystathionine beta-synthase mutations in homocystinuria","volume":"13","author":"Kraus","year":"1999","journal-title":"Hum Mutat"},{"key":"B23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1093\/emboj\/20.15.3910","article-title":"Structure of human cystathionine \u03b2-synthase: a unique pyridoxal 5\u2032-phosphate-dependent heme protein","volume":"20","author":"Meier","year":"2001","journal-title":"EMBO J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e105308","DOI":"10.1371\/journal.pone.0105290","article-title":"Domain organization, catalysis and regulation of eukaryotic cystathionine beta-synthases","volume":"9","author":"Majtan","year":"2014","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1586\/17512433.2015.1011175","article-title":"Homocysteine and the pathogenesis of atherosclerosis","volume":"8","author":"McCully","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3390\/ijms20040867","article-title":"The contribution of homocysteine metabolism disruption to endothelial dysfunction: state-of-the-art","volume":"20","author":"Esse","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.25011\/cim.v17i4.929","article-title":"Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid","volume":"17","author":"Rozen","year":"1994","journal-title":"Clin Invest Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/BF02141817","article-title":"Two novel missense mutations in the cystathionine beta-synthase gene in homocystinuric patients","volume":"96","author":"Kluijtmans","year":"1995","journal-title":"Hum Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/01.ATV.20.5.1392","article-title":"Familial thrombophilia associated with homozygosity for the cystathionine beta-synthase 833T\u2192C mutation","volume":"20","author":"Gaustadnes","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e12844","DOI":"10.1002\/jimd.12844","article-title":"E-HOD consortium. Cystathionine \u03b2-synthase deficiency in the E-HOD registry-part II: dietary and pharmacological treatment","volume":"48","author":"Morris","year":"2025","journal-title":"J Inherit Metab Dis"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1825770\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:46:59Z","timestamp":1781848019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1825770\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":31,"alternative-id":["10.3389\/fcvm.2026.1825770"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1825770","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"article-number":"1825770"}}